Further characterization of the circulating cell in chronic lymphocytic leukemia
- PMID: 1065390
Further characterization of the circulating cell in chronic lymphocytic leukemia
Abstract
Peripheral lymphocytes from normal individuals and from patients with chronic lymphocytic leukemia (CLL) were cultured in vitro for 1-7 days. The growth response to phytohemagglutinin (PHA) was quantitated by the incorporation of tritiated uridine into RNA nucleotide during a 2-hr pulse with the radioisotope. While the maximum response in PHA-stimulated normal cultures appeared at 2-3 days, CLL cultures required 5-7 days to develop their maximal response, which was 50%-60% of the normal magnitude. Dilution of the number of normally reactive lymphocytes by culturing them with totally unreactive, mitomycin-treated cells produced a normal 72-hr maximal response, no matter what proportion of unreactive cells was included in the PHA-stimulated cultures. In addition, the response of peripheral lymphocytes from patients with myeloblastic leukemia, where large numbers of unreactive myeloblasts diluted the normal small lymphocytes, a depressed reaction occurred at the anticipated 2-3 days. Nylon fiber-adherent lymphocytes consisting of 85% immunoglobulin (Ig)-bearing cells responded minimally to PHA, but showed no evidence of a delay. When isolated from CLL patients, both fiber-adherent cells (Ig-bearing) as well as non-fiber-adherent (sheep erythrocyterosetting) cells responded to PHA in a delayed fashion. Similarly, a case of CLL, in which 93.5% of the circulating lymphocytes bore sheep red blood cell receptors, showed its peak response to PHA at 7 days. Therefore, using surface marker criteria considered characteristic of normal T cells and B cells, the delayed response to PHA on the part of CLL lymphocytes was independent of thymic or nonthymic origin.
Similar articles
-
Mitogen stimulation of chronic lymphocytic leukemic lymphocytes: defective phytohemagglutinin stimulation independent of immunologic cell surface markers.Blood. 1980 Aug;56(2):256-61. Blood. 1980. PMID: 6156728
-
[T- and B-lymphocytes in lymphoproliferative diseases].Vopr Onkol. 1978;24(1):11-6. Vopr Onkol. 1978. PMID: 305684 Russian.
-
Structure and biological functions of human IgD. XII. Anti-IgD enhancement of PHA responsiveness in patients with chronic lymphocytic leukaemia.Clin Exp Immunol. 1977 Dec;30(3):450-6. Clin Exp Immunol. 1977. PMID: 414869 Free PMC article.
-
Lymphocyte immunological patterns in leukaemia: a review.Haematologia (Budap). 1975;9(1-2):21-33. Haematologia (Budap). 1975. PMID: 780227 Review.
-
Immunologic cell features in lymphocytic leukemias: a review.Boll Ist Sieroter Milan. 1975 Jun 26;54(2):108-19. Boll Ist Sieroter Milan. 1975. PMID: 54182 Review.
Cited by
-
Chronic lymphocytic leukemia: temporal changes in numbers of T-lymphocytes.Can Med Assoc J. 1980 Apr 19;122(8):914-6. Can Med Assoc J. 1980. PMID: 6966180 Free PMC article. No abstract available.
-
Mechanisms of lymphocyte activation: the role of suppressor cells in the proliferative responses of chronic lymphatic leukemia lymphocytes.J Clin Invest. 1979 Jan;63(1):67-74. doi: 10.1172/JCI109280. J Clin Invest. 1979. PMID: 153914 Free PMC article.
-
B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukaemia.Clin Exp Immunol. 1978 Aug;33(2):302-8. Clin Exp Immunol. 1978. PMID: 309812 Free PMC article.
-
Abnormal T-cell functions in B-cell chronic lymphocytic leukemia do not imply T-lymphocyte involvement in the leukemic process: report of a case with demonstrated "polyclonality" of T lymphocytes.J Clin Immunol. 1983 Apr;3(2):111-6. doi: 10.1007/BF00915481. J Clin Immunol. 1983. PMID: 6602144
-
PHA-induced soluble factor(s) can activate B-cells from patients with chronic lymphatic leukaemia.Clin Exp Immunol. 1979 Sep;37(3):517-22. Clin Exp Immunol. 1979. PMID: 315847 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources